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Uptake, metabolism, and stabilization o f xanthophyll 
earotenoids in  the retina are thought to be m ediated by 
specific xanthophyll-binding proteins (XBPs). A mem- 
brane-assoeiated XBP w as purified from human macula 
using ion-exchange chromatography followed by gel-ex- 
clusion chromatography. Two-dimensional gel electro­
phoresis showed a prom inent spot o f 23 kDa and an 
isoelectric point o f 5.7. U sing m ass spectral sequencing  
m ethods and the public NCBI database, it  w as identified  
as a Pi isoform o f human glutathione S-transferase 
(GSTP1). Dietary (3U,3'I?)-zeaxanthin displayed the 
highest affinity w ith an apparent K d o f 0.33 fiM, followed  
by (3U,3'S-meso)-zeaxanthin w ith  an apparent K d o f 0.52 
/J.M. (3U,3'I?,6'I?)-Lutein did not display any high-affinity 
binding to GSTP1. Other human recom binant glutathi­
one S-transferase (GST) proteins, GSTA1 and GSTM1, 
exhibited only low affinity binding o f xanthophylls. 
(3U,3'S-meso)-Zeaxanthin, an optically inactive non­
dietary xanthophyll carotenoid present in  the human 
macula, exhibited a strong induced CD spectrum  in as­
sociation w ith human m acular XBP that w as nearly 
identical to the CD spectrum induced by GSTP1. Like­
w ise, dietary (3U,3'I?)-zeaxanthin displayed alterations 
in  its CD spectrum in association w ith  GSTP1 and XBP. 
Other mammalian xanthophyll carrier proteins such as 
tubulin, high-density lipoprotein, low-density lipopro­
tein, albumin, and /j-laetoglobulin did not bind zeaxan- 
thins w ith  high affinity, and they failed to induce or 
alter xanthophyll CD spectra to any significant extent. 
Immunocytochemistry w ith  an antibody to GSTP1 on 
human m acula sections showed highest labeling in  the 
outer and inner plexiform layers. These results indicate  
that GSTP1 is a specific XBP in human m acula that 
interacts w ith  (3R,3'S-m eso)-zeaxanthin and dietary 
(3U,3'I?)-zeaxanthin in contrast to apparently weaker  
interactions w ith  (3U,3'I?,6'I?)-lutein.
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Carotenoids are ubiquitous highly colored pigments synthe­
sized exclusively by p lants and microorganisms. Over 600 caro­
tenoids have been isolated from natu ra l sources, and —370 of 
these carotenoids are chiral, bearing one to five asymmetric 
carbon atoms (1). Many carotenoids are classified as xantho­
phylls because they contain a t least one oxygen atom along 
their C40H66 isoprenoid core structure. H igher anim als cannot 
synthesize carotenoids, bu t they can ingest them in their diet 
and subsequently utilize them for im portant physiological 
functions. W hereas >15 different dietary carotenoids are de­
tectable in hum an serum , only lutein ((3i?,3'i?,6'i?)-p,€-caro- 
tene-3,3'-diol) and zeaxanthin (a m ixture of (3i?,3'.R)-j3,j3-caro- 
tene-3,3'diol and (3i?,3'jS-meso)-j3,j3-carotene-3,3'-dioD (see Fig. 
1) and their m etabolites are found to any substantial extent in 
the retina (2—4). High m acular levels of these antioxidant and 
blue light-screening xanthophyll carotenoids are associated 
w ith decreased risk of age-related m acular degeneration (5, 6 ), 
the leading cause of blindness in the developed world.
In the foveal region of the m acula of the prim ate retina, 
lutein and zeaxanthin concentrations are a t the ir highest, and 
they are spatially localized to the outer plexiform layer (also 
known as the receptor axon or Henle fiber layer) and to the 
inner plexiform region (7). The concentration of the m acular 
carotenoids falls precipitously outside of the foveal region, so 
th a t the concentration of lutein and zeaxanthin in the periph­
eral retina per un it area is 1% of the concentration a t the fovea 
(8 ), and a considerable portion of the extrafoveal carotenoids is 
associated w ith the rod outer segments (9, 10).
W henever a tissue exhibits highly selective uptake and dep­
osition of biological molecules, it is likely th a t specific binding 
proteins are involved. These binding proteins may act as cell 
surface receptors, transm em brane transport proteins, m eta­
bolic enzymes, intracellu lar m ediators of the biological actions 
of the ligand, or sites for the deposition and stabilization of the 
ligand. Carotenoid-binding proteins have been described in 
plants (11), microorganisms (12,13), and invertebrates (14,15), 
but relatively little information has been available about spe­
cific carotenoid-binding proteins in any vertebrate system. In 
1997, Rao et al. (16) reported the existence of a j3-carotene- 
binding protein in ferret liver, although no sequence data  have 
been provided yet. More recently, we have described the prop­
erties of a partially  purified membrane-associated xanthophyll- 
binding protein (XBP)1 found in hum an retina and m acula (17,
1 The abbreviations used are: XBP, xanthophyll-binding protein; 
CHAPS, 3-l(3-cholamidopropyl)dimethylammonioJ-l-propanesulfonic 
acid; GST, glutathione S-transferase; GSTA, glutathione S-transferase 
Alpha; GSTM, glutathione S-transferase Mu; GSTP, glutathione S- 
transferase Pi; HDL, high-density lipoprotein; IEF, isoelectric focusing;























F ig. 1. S tru c tu re s  of xan thophy ll caro teno id s found  in  hum an  
re tin a .
18). We have also reported th a t retinal tubulin exhibits carot­
enoid binding properties (19, 20), but w ith less specificity and 
affinity than  XBP (17). Likewise, several other mam m alian 
proteins such as high-density lipoprotein (HDL), low-density 
lipoprotein (LDL), albumin, and 0-lactoglobulin can act as car­
rier proteins for carotenoids, although there is no evidence th a t 
they do so with high specificity or affinity (17, 21-23).
In this study, we further purify hum an m acular XBP and 
identify the major protein spot on two-dimensional gels as a Pi 
isoform of glutathione S -transferase (GSTP1). Pharmacological 
and spectroscopic binding studies with hum an recombinant 
GSTP1 dem onstrate th a t its interactions with zeaxanthin 
closely match those of XBP purified from hum an macula.
EXPERIMENTAL PROCEDURES
Preparation o f Solubilized Membrane Extracts from Hum an M acu­
la—Preparation of XBP was based on previously published methods 
(17J, w ith minor modifications. Thawed hum an m aculae (6 -8  mm 
punches) originating from 15 postmortem eyes (average age, 40 ± 10 
years) were homogenized in 1.0 ml of a cell lysing solution containing 
protease inhibitors (Roche Diagnostics,! in 20 m M  Tris buffer (pH 7.4,) 
supplemented w ith 1 m M  CaCl2, 2 m M  MgCl2, and 15% (w/v,> sucrose. 
Sucrose density gradient (5-50% (w/v)) centrifugation a t 5,000 x  g  for 
30 min a t 2 °C resulted in a low-densitv vellow-colored band containing 
XBP. The yellow fraction was diluted with T ris buffer (pH 7.4,) to bring 
the sucrose concentration down to 5% (w/v,).
A high-speed ultracentrifugation of the diluted yellow fraction was 
performed a t 200,000 x  g  for 60 m in a t 2 °C. The high-speed superna­
ta n t was discarded, and the yellow high-speed pellet was solubilized 
with brief sonication on ice into 500 /id of 25 m M  CHAPS in 20 m M  MES 
buffer (pH 5.5,) containing 1 m M  CaCl2 and 2 m M  MgCl2, followed by 
centrifugation a t 100,000 x  g  for 60 min a t 2 °C. The CHAPS-insoluble 
pellet was resolubilized into CHAPS/MES buffer several more times, 
followed by high-speed centrifugation as described above. The pale 
yellow CHAPS-solubilized su pem atan ts were combined and concen­
tra ted  to 500 /id  using an U ltrafree centrifugal filtration system (Milli- 
pore, Woburn, MA; molecular m ass cutoff, 10 kDa).
Ion-exchange Chromatography and Silica Gel Chromatography o f  
XBP—Protein chromatography was performed on a BioLogic liquid 
chromatography system (Bio-Rad,). Detergent-solubilized hum an mac­
u lar m em brane extracts were loaded immediately after preparation 
onto an  Am ersham  Biosciences S cation-exchange column (7 x  35 mm, 
SO„ exchanging groups,). Initial buffer conditions were 20 m M  MES 
buffer containing 8 m M  CHAPS a t pH 5.5 ru n  a t 0.5 ml/min a t 4 °C for 
15 min, followed by a linear gradient from 0 to 1 M NaCl over 15 min. At 
la te r purification stages, anion-exchange chromatography was per­
formed on an Am ersham  Biosciences Q column (7 x  35 mm, N(CH,),! 
exchanging groups). Initial buffer conditions were 20 m M  Tris buffer
LDL, low-density lipoprotein; MALDI, m atrix-assisted laser desorption 
ionization; MES, 4-morpholineethanesulfonic acid; THF, tetrahydrofu- 
ran; HPLC, high-performance liquid chromatography; PBT, phosphate 
buffer containing 0.1% Triton X-100.
(pH 7.4,) containing 8 m M  CHAPS, followed by a linear gradient from 0 
to 1 M NaCl over 20 min. Silica gel chromatography was done using a 
silica gel filtration column (BIOSEP-SEC-S 3000 PEEK; 300 x  7.80 
mm; separation range, 5-700 kDa; Phenomenex, Torrance, CA,). Con­
centrated fractions (up to 200 /id ) from the ion-exchange columns were 
loaded onto the gel filtration column, and 50 m M  sodium phosphate 
buffer (pH 7.0) containing 8 m M  CHAPS was used as the e luan t a t a 0.3 
ml/min flow ra te . At all stages of chromatographic purification, the 
eluates were monitored by a UV6000LP photodiode array  spectropho­
tom eter equipped with a high sensitivity 50 mm pathlength light-pipe 
flowcell w ith an  in ternal volume of 10 /id  (Thermo Separations, San 
Jose, CA,), and 300 /id fractions were collected. The fractions of in terest 
containing proteins associated with endogenous m acular carotenoids 
exhibited strong 280 nm protein absorbance and prom inent triple peak 
vibronic structure centered a t -4 6 0  nm, typical of most xanthophyll 
carotenoids.
Carotenoid Extraction and HPLC^ F if ty  /id  of purified fractions a t 
each stage of column chromatography were treated  w ith 100 /id  of 
methanol to disrupt ligand-protein associations, and they were then  
extracted into 200 /id of hexane. Phase separation was promoted by the 
addition of 20 /id of sa tu rated  sodium chloride. The organic extracts 
were dried bv vacuum evaporation in a Speedvac Plus (SC110; Savant, 
Cambridge, MA,) and redissolved in 1 ml of HPLC mobile phase (hex- 
aneidichloromethaneimethanoliA^iV'-di-isopropylethylamme, 80:19.2:
0.7:0.1 (v/v,),). HPLC separation was carried out a t a flow ra te  of 1.0 
ml/min on a cyano column (Microsorb 25-cm length X 4.6-mm inner 
diam eter; Varian Inc., Palo Alto, CA,). The column was m aintained at 
room tem perature, and the HPLC detector was operated a t 450 nm. 
Peak identities were confirmed by photodiode array  spectra and by 
coelution w ith authentic standards as necessary. Peak areas were in­
tegrated and quantified with an  external standardization curve.
Two-dimensional Isoelectric Focusing and Electrophoresis—Isoelec­
tric focusing (IEF,) separations were done using precast immobilized pH 
gradient gel strips (pH 5-8 ; strip length, 11 cm; Bio-Rad,). The immo­
bilized pH gradient strips were rehydrated overnight in trays loaded 
with the protein samples in  the  m anufacturer’s sample buffer. Isoelec­
tric focusing was performed in a Bio-Rad Protean IEF cell un it a t 20 °C, 
with a maximum current of 50 /iiA/strip. The end voltage for the  IEF run  
was 8,000 V. The strips were equilibrated with buffers containing 
dithiothreitol and iodoacetamide. After SDS-PAGE on a 1-mm-thick 
4-20%  gradient Tris-HCl gel, protein spots were stained w ith fluores­
cent Sypro Ruby protein sta in  (Bio-Rad,). Gels were then visualized and 
documented (AlphaDigiDoc 1201; Alpha Innotech, San Leandro, CA,) 
using a UV light source. Detected spots were processed for m ass spec­
tra l identification.
M ass Spectral Protein Identification—Excised protein samples were 
digested in-gel with sequencing-grade modified trypsin (Promega), ac­
cording to a previously reported m ethod (24,). Digests were desalted and 
concentrated to 4 /id  by solid-phase extraction using /11C I8 ZipTips 
(Millipore, Billerica, MA,). The m atrix-assisted laser desorption ioniza­
tion (MALDI,) p late was then  spotted w ith 1 /id of sample and 1 /id of 
«-cyano-hydroxycinnamic acid as the m atrix. Mass spectrom etry em­
ployed a QSTAR Pulsar instrum ent equipped w ith a MALDI source 
(Applied Biosystems, Fram ingham , MA,). Fragm entation by collision- 
induced dissociation was performed on paren t ions representing each 
peptide. The collision-induced fragm entation spectrum  for each parent 
ion was then subm itted to the Mascot web site (Matrix Science, London, 
United Kingdom,) for database searching.
Carotenoid B inding Assays—Synthetic (3R,3'R)-zeaxanthin and 
(3R,3'S-me6-o,>-zeaxanthin were gifts from DSM N utritional Products 
(Kaiseraugst, Switzerland,), and (3R,3'R,6'R)-lutein prepared from 
marigold flowers was a gift from Kemin Foods (Des Moines, IA,>. XBP 
requires CHAPS detergent to m aintain  solubility and stability during 
purification, and the CHAPS detergent also aids in solubilizing the 
xanthophyll carotenoid ligands; therefore, all carotenoid binding exper­
im ents for XBP and other proteins were done in the presence of iden­
tical concentrations of CHAPS. In a typical binding experiment, 10 /id of 
concentrated carotenoids (1-250 /iiM) dissolved in tetrahvdrofuran 
(THF) were added to 490 /id of 50 m M  Tris-CHAPS (8 m M ) buffer 
containing 1 /iig of protein ( -  0.1 /iiM, based on a subunit molecular mass 
of 23 kDa). After b rief mixing, the m ixture was incubated overnight (16 
h) a t 4 °C. Kinetic binding studies w ith (3R,3'R,6'R)-lutein, (3R,3'R)- 
zeaxanthin, and (3R,3'S-me6-o)-zeaxanthin dem onstrated th a t equilib­
rium  was reached within 12-14 h. Unbound carotenoids were removed 
by four cycles of extraction w ith 200 /id of hexane, followed by centrif­
ugation for 5 m in a t 1,800 X g i n a  microcentrifuge and removal of the 
organic solvent layer. Residual hexane was removed from the extracted 























protocol as the preferred organic solvents for carotenoid delivery and 
extraction because they do not typically lead to denaturation of carote- 
noid-binding proteins (16, 17). During all experimental procedures, the 
samples remained clear, with no signs of precipitation. In many cases, 
UV-visible absorption and CD spectra w ere measured before extraction 
and HPLC carotenoid analysis.
Computerized nonlinear regression analyses of binding param eters 
using one- and two-site models were performed using PRISM version 
3.0 (GraphPad Software Inc., San Diego, CA). All binding curves and 
calculations were corrected for nonspecific binding by subtracting pa r­
allel incubations in which protein had been omitted. Binding assays 
were performed in a sim ilar m anner a t equivalent protein concentra­
tions with hum an recombinant glutathione S-transferase isoforms 
GSTP1, GSTA1, and GSTM1, and with other mammalian carotenoid 
carrier proteins, bovine brain tubulin, hum an serum  HDL, hum an 
serum  LDL, bovine milk £S-lactoglobulin, and hum an serum  albumin 
(essentially fa tty  acid-free). All of these commercially prepared proteins 
were obtained from Sigma.
Spectral Measurements—CD spectra were recorded a t 4 °C ± 0.2 °C 
with an Aviv Associates CD spectrophotometer (Model 62 DS; Lake­
wood, NJ). Spectra were recorded a t a scan speed of 10 nm/min and a 
spectral bandwidth of 1.0 nm. Quartz cells with pathlengths of 1 mm 
were used for all CD m easurem ents, and the  spectra were obtained in 
the wavelength range of 200-700 nm. Each spectrum  was the average 
of 10 replicate scans in steps of 1 nm. All m easurem ents w ere reported 
in millidegrees of ellipticity (m0). The UV-visible absorption m easure­
ments on the  sam ples were done using an absorption spectrophotome­
te r  (Lambda 9; PerkinElm er Life Sciences) a t room tem perature a t a 
scan speed of 30 nm/min with 1 nm resolution in quartz  cells with 
pathlengths of 1 mm.
Immunocytochemistry and Western Blotting—Hum an donor eyes 
were obtained from the  U tah Lions Eye Bank (Salt Lake City, UT). 
After removal of the anterior segm ent and vitreous, the  eye cup from a 
23-year-old m ultiple organ donor was fixed 3 h post-mortem using 
freshly prepared 4% paraform aldehyde in 0.1 M phosphate buffer (pH 
7.4) for 90 min, rinsed, and cryoprotected overnight in 30% sucrose in 
buffer. Subsequently, a rectangular piece of retina centered approxi­
mately on the  fovea was isolated, embedded in TBS tissue-freezing 
medium (Triangle Biomedical Sciences, Durham , NC), and frozen. 
Cryosections (14 firm thick) were cut, rinsed in 0.1 M PBT, and blocked 
for 1 h using 10% normal donkey serum  in PBT. Antibodies to GSTP1 
(Alpha Diagnostic International, San Antonio, TX; GSTP1-S; 1:200 
dilution) and cone arrestin  (7G6 from Peter R. MacLeish; Morehouse 
School of Medicine, A tlanta, GA; 1:500 dilution) were applied overnight 
a t 4 °C. The polyclonal antibody against GSTP1 was raised in rabbit 
using HPLC-purified ra t protein as the  immunogen. After rinsing in 
three  10-min PBT washes, rhodamine- and fluorescein isothiocyanate- 
conjugated secondary antibodies (Jackson ImmunoResearch Laborato­
ries, W est Grove, PA; catalog no. 711-295-152 and 715-096-150; each 
used a t  a 1:200 dilution) were applied for 2 h a t room tem perature to 
visualize sites of label. The immunolocalization was imaged using a 
Zeiss LSM 510 confocal microscope set to an optical slice of <0.9 firm. 
Control sections, in which incubation in prim ary antibodies was omit­
ted, were processed in parallel and found to be negative for 
immunoreactivity.
Protein samples were separated on SDS-PAGE and transferred to 
nitrocellulose filters using a Bio-Rad frans-blot apparatus a t 100 V for 
2 h. Nonspecific binding was blocked by immersing the  membrane in 5% 
nonfat dried milk, 0.1% Tween 20, in 1% donkey serum  in phosphate- 
buffered saline for 1 h a t room tem perature on an orbital shaker. The 
membrane was briefly rinsed with two changes of wash buffer and 
incubated with diluted prim ary antibody (1:400; rabbit an ti-ra t GSTP1) 
for 1 h a t room tem perature on an orbital shaker. After two changes of 
wash buffer, peroxidase-conjugated affinity-purified secondary an ti­
body was diluted in phosphate-buffered saline (1:800; donkey an ti­
rabbit IgG; catalog no. 711-035-1520; Jackson ImmunoResearch Labo­
ratories). The m embrane was incubated in the diluted secondary 
antibody for 1 h a t  room tem perature on an orbital shaker and then 
developed using ECL Plus W estern blotting detection reagents (Amer- 
sham  Biosciences).
RESULTS
P urifica tion  o f  H u m a n  M acu lar X B P —We have reported 
previously th a t partially  purified m em brane preparations from 
hum an m acula have saturable and specific binding sites for 
xanthophyll carotenoids (17). As described under “Experim en­
tal Procedures,” we have improved the XBP purification proto-
Fig. 2. E lu tion  p a tte rn  of hum an  m acu la r XBP on a  silica  gel 
ch rom atog raph ic  colum n. Contour view of the  on-line photodiode 
array  scan of the chromatographic purification of XBP (top panel). 
Absorbance spectrum  of purified XBP eluting from the silica gel column 
a t 32 min compared with th a t of (3R,3'R)-zeaxanthin and (3R,3'R,6'R)- 
lutein standards dissolved in THF (bottom panel). There is a bathochro- 
mic shift of the  absorbance peaks of XBP (438, 468, and 488 nm) relative 
to zeaxanthin (425, 456, and 478 nm) and lutein (425, 450, and 476 nm).
col by the addition of a sucrose gradient centrifugation step 
before detergent solubilization and by enhanced chromato­
graphic separations. XBP is a membrane-associated protein; 
therefore, it is necessary to use detergents to solubilize the 
protein during chromatographic separations. O ur previously 
reported protocol for purification of XBP utilized CHAPS, an 
excellent detergent for studying membrane-associated proteins 
(17, 25). CHAPS, like most detergents useful in protein purifi­
cations, is a chiral molecule (26). Because these chiral deter­
gents can complicate interpretation of circular dichroism stud­
ies performed for characterization of proteins, we also explored 
the use of nonchiral detergents such as Triton X-100 for puri­
fication. U nfortunately, XBP was unstable in all nonchiral 
detergents th a t we examined. Thus, all protein studies re­
ported here included CHAPS in the buffer, and suitable con­
trols were always incorporated in the experimental protocols to 
correct for the presence of a chiral detergent.
The light yellow XBP fraction th a t elutes from the final silica 
gel chromatography step exhibits a characteristic carotenoid 
absorbance profile, displaying a prim ary peak a t 468 nm, with 
secondary peaks a t 438 and 488 nm (Fig. 2). HPLC analysis of 
the most purified fractions confirms th a t both zeaxanthin and 
lutein are present in a ratio  of 2.5:1. XBP purified from hum an 
m acula carrying only endogenous carotenoids displayed a con­
sistent A460/A28o of —0.5. Addition of sa tu ra ting  am ounts of 
exogenous lutein or zeaxanthin to XBP, followed by hexane 























Zeaxanthin Binding to GSTP1
Fig. 3. Two-dim ensional IE F and  SDS-PAGE of hu m an  m acu­
la r  XBP. An aliquot of highly purified XBP was subjected to isoelectric 
focusing and SDS-PAGE analysis according to the  procedure detailed 
under “Experim ental Procedures." Protein spots were stained with flu­
orescent Sypro Ruby protein stain and then visualized using a LTV light 
source. Spot A  is GSTP1. The other spots (B -D )  have not yet been 
identified.
A46(/A 280 ratio  to 1.5, indicating th a t chromatographically pu ­
rified m acular XBP is —30% saturated  with endogenous 
carotenoids.
M ass SpectraI A n a lys is  o f  H igh ly  P urified  H u m a n  M acular  
X B P —One-dimensional SDS-PAGE gels of chrom atographi­
cally purified hum an m acular XBP have only a single major 
band a t —23 kDa, but two-dimensional IEF/SDS-PAGE reveals 
th a t there are actually four 21-23-kDa spots w ith isoelectric 
points ranging from 5.7 to 7.5 when stained with Sypro Ruby. 
These are designated as spots A -D  in Fig. 3. Because it is the 
strongest staining and presum ably the most abundant protein 
in our XBP fraction, we first performed m ass spectral sequenc­
ing on spot A (isoelectric point, 5.7). We reproducibly detected 
three strong tryptic peptides a t m l  z  1337.7,1883.9, and 2126.2 
on several two-dimensional gels from independent p repara­
tions. These peptides were fu rther analyzed using collision- 
induced fragm entation techniques to obtain additional se­
quence information on them. Using a Mascot search engine and 
the public NCBI database, we were able to positively identify 
spot A as GSTP1. The three peptides correspond to the se­
quences PPYTW YFPVR, FQDGDLTLYQSNTILR, and AL- 
PGQLKPFETLLSQNQGGK, covering 22.5% of the 209-amino 
acid sequence of GSTP1 a t positions 1—11, 55-70, and 121-140. 
Our MS/MS spectra match fragm entation pattern s predicted 
from these sequences.
Spot B w as observed to have an isoelectric point of 7.5. 
Tryptic digestion and m ass spectrometry yielded strong molec­
u lar ions of m / z  1654.8 and 1745.8. On further examination of 
their MS/MS spectra, it is clear th a t these two species are 
related; the apparent peptide a t m / z  1745.8 is actually the 
1654.8 peptide with an as yet undefined posttranslational mod­
ification. N either of the collision-induced fragm entation spec­
tra  from these paren t ions m atches any fragm entation patterns 
predicted for peptides in the public or private databases, and 
the MS/MS spectra have not been suitable for definitive de novo 
sequencing. Spots C and D w ith molecular m asses of 21-23 
kDa and isoelectric points of 6.2 and 6.5, respectively, have not 
yet been identified.
X a n th o p h yll B in d in g  a n d  Spectra l S tu d ie s  w ith  G STP1 and  
X B P —Binding of exogenous dietary (3i?,3'i?)-zeaxanthin and 
nondietary (3i?,3 'S-7neso)-zeaxanthin to recom binant hum an
Fig. 4. B inding  s tud ies of GSTP1, GSTM1, an d  GSTA1 w ith  
m acu la r xan thophylls . Ten /ill of concentrated (3iJ,3'iJ)-zeaxanthin 
(top panel), (3-fi.3'S-meso)-zeaxanthin (middle panel), and (3R,3'R, 
6'i2)-lutein (bottom- panel) dissolved in THF were added to 490 /ill of 50 
m M  Tris-CHAPS (8 m M ) buffer containing 1 /iig of the  three  GST iso­
forms (GSTP1, ■: GSTM1, ▼; GSTA1, O). After brief mixing, the  mix­
tures were incubated overnight (16 h) a t 4 °C. Unbound carotenoids 
were removed by four cycles of extraction with 200 /d of hexane. Only 
GSTP1 exhibited definite saturable binding with a Kd of 0.33 /.m with 
(3-fi.3'-fi)-zeaxanthin and a Kd of 0.52 /iim with (3-fi.3'S-meso)-zeaxan- 
thin. Two zeaxanthins were bound per 23-kDa GSTP1 subunit. 
(3-fi.3'-fi,6'-fi)-Lutein did not bind to any of the  GST isoforms saturably 
or with high affinity. The means ± S.D. for th ree  independent incuba­
tions are shown.
GSTP1 was saturable w ith apparent dissociation constants of
0.33 and 0.52 /um (Fig. 4), respectively, somewhat lower than 
the dissociation constants of 1-2  /um th a t we reported previ­
ously for the interaction of partially  purified hum an m acular 
XBP w ith lutein and zeaxanthin (17). The ligand/protein ratio 
for both forms of zeaxanthin to the 23-kDa monomer of GSTP1 
was observed to be 2.0 a t saturation, and two-site binding 























binding studies generally did not have glutathione present in 
the buffer, and the addition of up to 1 m M  glutathione did not 
alter zeaxanthin binding to GSTP1. We were unable to assess 
the im pact of xanthophyll binding on the GST activity of 
GSTP1 because the CHAPS detergent required for xanthophyll 
binding inhibited its GST activity. When we examined other 
GST isoforms such as hum an recom binant GSTM1 and GSTA1, 
we observed low-affinity binding w ithout definite evidence of 
saturation (Fig. 4). Although we have dem onstrated previously 
th a t hum an m acular XBP can bind exogenous lutein (17), we 
were unable to dem onstrate high-affinity specific binding of 
lutein to any of the three isoforms of recom binant hum an GST 
(Fig. 4). We also compared GSTP1 with a series of mammalian 
proteins thought to in teract w ith xanthophyll carotenoids (tu­
bulin, albumin, HDL, LDL, and j3-lactoglobulin). No high-affin- 
ity saturable zeaxanthin binding comparable with GSTP1 was 
detectable (Fig. 5), although albumin did exhibit saturable 
high-affinity binding for lutein (Kd, 0.54 /u m ; 3 binding 
sites/molecule).
The binding behavior of dietary (3i?,3'i?)-zeaxanthin and 
nondietaiy (3i?,3'S-nteso)-zeaxanthin to GSTP1 was further 
characterized using absorption and CD spectroscopy. The ab­
sorption spectrum  of purified XBP carrying its endogenous 
carotenoid ligands displayed a bathochromic shift of 9 -12  nm 
as compared with the spectrum  of lutein and zeaxanthin in 
organic solvents (Fig. 2). The visible spectrum  of XBP is iden­
tical to th a t of the m acular carotenoid pigm ent in  vivo  (8 - 10). 
GSTP1 apoprotein had no visible absorbance.
The far-UV CD spectrum  of native XBP displayed a negative 
Cotton peak a t 220 nm, which is typical of a protein with 
dom inant a-helix structure (27), w hereas the hum an recombi­
n an t GSTP1 apoprotein had a far-UV CD peak a t 213 nm. The 
visible-range CD spectrum  between 300 and 700 nm  of XBP 
bearing its endogenous ligands w as w eak and complex with 
m inor positive and negative peaks a t 400 and 494 nm, respec­
tively, w hereas the GSTP1 apoprotein had no detectable visi­
ble-range CD. Addition of exogenous sa tu ra ting  am ounts of 
either form of zeaxanthin to XBP or GSTP1 resulted in sub­
stan tia l alterations of their visible and CD spectra (Figs. 6 and 
7). The three visible absorption peaks of XBP had a bathochro­
mic shift of 8 -1 0  nm  relative to the spectrum  of zeaxanthin 
solubilized in THF or CHAPS, and the bathochromic shifts of 
GSTP1 were even larger (19-21 nm). The far-UV negative CD 
peak of GSTP1 shifted to 219 nm  after binding either form of 
zeaxanthin, closely m atching th a t of hum an m acular XBP car­
rying its native ligands.
As expected, nonchiral (3i?,3'S-meso)-zeaxanthin has no de­
tectable CD when dissolved in THF, a nonchiral solvent. In 
CHAPS, a chiral detergent, there was likewise no detectable 
CD, indicating th a t the (3i?,3'S-meso)-zeaxanthin dissolved in 
the detergent micelles w as unconstrained and unaggregated 
(Fig. 6). (3i?,3'S-meso)-Zeaxanthin displayed a definite induced 
circular dichroism with a positive Cotton effect a t 419 nm  and 
a negative Cotton effect a t 490 and 529 with a zero crossover 
point a t 460 nm  when bound to recom binant GSTP1, corre­
sponding well w ith the somewhat weaker visible-range CD of 
XBP sa tu ra ted  with exogenous (3i?,3'S-meso)-zeaxanthin (Fig. 
6). The intensities of the induced Cotton effects increased with 
the ligand/protein ratio, and saturation was observed a t a 
ligand/protein ratio  of 2 in agreem ent with the binding studies.
Unlike (3i?,3'S-meso)-zeaxanthin, dietary (3i?,3'i?)-zeaxan- 
thin has a strong CD spectrum  in any solvent. In THF, its CD 
spectrum  is strongest in the UV range (Fig. 6), and the weak 
signals in the visible range are usually considered to be arti- 
factual (28, 29). When dissolved in CHAPS, the UV CD of 
(3i?,3'i?)-zeaxanthin is no longer detectable, w hereas a nega-
Fio. 5. B inding  s tud ies  of G STP1, tubu lin , album in, HDL, LDL, 
an d  j3-lactoglobulin w ith  m acu la r xanthophylls. Ten /xl of concen­
tra ted  (3i?,3'i?)-zeaxanthin (top panel), (3i?,3'S-«K'so)-zeaxanthin (m id ­
dle panel), and (3/f,37f,67f)-lutein (bottom, panel) dissolved in  THF 
were added to 490 ju,l of 50 m M  Tris-CHAPS (8 m M ) buffer containing 1 
fig of protein (GSTP1, ■: bovine b rain  tubulin, ▼; hum an serum  albu­
min, □ ; hum an HDL, ▲; hum an LDL, ♦ ; bovine p-lactoglobulin, • ) .  
After b rief mixing, the m ixtures were incubated overnight (16 h) a t 
4 °C. Unbound carotenoids were removed by four cycles of extraction 
with 200 fil of hexane. All da ta  points are single m easurem ents. The 
only definite saturable high-affinity binding interactions observed for 
the zeaxanthins were between GSTP1 and (3i?,37?)-zeaxanthin and 
between GSTP1 and (3i?,3'S-meso)-zeaxanthin (see Fig. 4 for GSTP1 
binding constants). Only album in exhibited high-affinity saturable 
binding for lutein  (A'rf, 0.54 j im ; 3 binding sites/album in molecule).
tive Cotton peak is present a t 410 nm, and a biphasic positive 
Cotton peak is present a t 480 and 500 nm. The crossover point 
is a t 430 nm, the visible absorption maximum of one of the 
vibronic peaks. When bound to XBP or GSTP1, these CD peaks 
shift bathochromically by 10-20 nm. The red-shifted visible 
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Fig. 6. Induced  and  a lte red  CD spec tra  o f zeaxan th in s  bound  to  GSTP1 and  hu m an  m acu la r XBP. Saturating  am ounts of (3R,3'R)- 
zeaxanthin (left column) and (3R,3'S-meso)-zeaxanthin (right column) were incubated with 1 /ng of hum an recombinant GSTP1 and with hum an 
m acular XBP overnight a t 4 °C, and unbound carotenoids were then removed by hexane extraction. Zeaxanthins dissolved a t sim ilar concentra­
tions in THF and in 8 m M  Tris-CHAPS buffer (pH 7.8) were used as controls. CD spectra were acquired as described under “Experim ental 
Procedures.”
both zeaxanthin diastereom ers when bound to GSTP1 or XBP 
are indicative of a  J-type association (loose type, head to tail) 
with supram olecular coupling between the two bound ligands 
(30, 31).
We also examined visible absorption and CD spectra of 
(3i?,3'S-meso)-zeaxanthin and (3R ,3 'R  (-zeaxanthin with 
GSTA1 and GSTM1 and a series of other mam m alian proteins 
thought to be relatively nonspecific low-affinity carriers of xan­
thophyll carotenoids (tubulin, albumin, LDL, HDL, and J3-Iac- 
toglobulin). In nearly all cases, the proteins induced no signif­
icant alterations in the visible absorption or CD spectra 
relative to the CHAPS control. The only exception was tubulin, 
which induced modest bathochromic shifts th a t were much 
lower in m agnitude than those seen with XBP or GSTP1.
Im m unoloca liza tion  o fG S T P l in  H u m a n  M acula—Immuno- 
localization with a monospecific polyclonal antibody to GSTP1 
on a hum an parafoveal section revealed th a t GSTP1 is ex­
cluded from nuclei but is otherwise present throughout the 
hum an macula, and it is especially concentrated in the outer 
plexiform layer (also known as the Henle fiber or receptor axon 
layer) and the inner plexiform layer (Fig. 8, red). S im ilar sec­
tions of more peripheral regions of the re tina  did not exhibit 
such intense GSTP1 labeling of the inner and outer plexiform
layers. The labeling with GSTP1 antibodies in the parafovea 
was contrasted with th a t of cone arrestin  (32) to dem onstrate 
the distribution and density of cone pedicles (Fig. 8, green). The 
observation of high levels o fG ST Pl in the parafoveal plexiform 
layers of the hum an m acula correlates well w ith the pigment 
distribution of the m acular carotenoids reported by Snodderly 
et al. ( 7).
DISCUSSION
Of more than 15 carotenoids typically detected in hum an 
serum , only 2, lutein and zeaxanthin, are present in the macula 
of the hum an eye, and their concentrations a t the fovea are 
extraordinarily high, on the order of 1 mM. Highly selective 
uptake of these two xanthophyll carotenoids implies the exist­
ence of specific XBPs, bu t until now, no saturable and specific 
vertebrate XBP has been positively identified. To identify a 
hum an m acular XBP, we have taken advantage of the very 
high endogenous levels of intensely colored lutein and zeaxan­
thin in the hum an m acula as a readily monitored m arker for 
proteins th a t copurify with xanthophyll carotenoids through 
m ultiple biochemical purification steps. In our most purified 
XBP preparations, we have only one major band a t 23 kDa th a t 























Fig. 7. A bsorp tion  sp ec tra  of zeaxan th in s bound  to  GSTP1 and  
hum an  m acu lar XBP. Saturating  am ounts of (3R,3'R)-zeaxanthin 
(top panel) and (3R,3'S-meso)-zeaxanthin (bottom panel) were incu­
bated with t  /ng of hum an recombinant GSTPt and with hum an mac­
ular XBP overnight a t 4 °C, and unbound carotenoids were then re­
moved by hexane extraction. Zeaxanthins dissolved a t sim ilar 
concentrations in THF and in 8 m M  Tris-CHAPS buffer (pH 7.8) were 
used as controls. Absorption spectra were acquired as described under 
“Experim ental Procedures."
most prom inent spot has a p i of 5.7, and we were able to 
positively identify it  as GSTP1 by in-gel tryptic digestion and 
m ass spectral sequencing. Biochemical and spectroscopic bind­
ing studies with hum an recom binant protein confirm th a t 
GSTP1 binds both physiological forms of zeaxanthin w ith high 
affinity and specificity.
GSTs are members of a  superfamily of phase II detoxification 
enzymes th a t consist of two identical 23-kDa subunits. They 
are best known to be involved in the conjugation of glutathione 
to various electrophilic m etabolites generated by oxidative pro­
cesses in the body. Based on the ir structural and functional 
properties, GSTs can be divided into a t least 12 different 
classes (Alpha, Beta, Delta, Kappa, Mu, Omega, Phi, Pi, Sigma, 
Tau, Theta, and Zeta) (33), and w ithin these classes, multiple 
subisoforms can exist. Only one Pi isoform of GST, GSTP1, is 
known to be expressed in hum an tissue, and its gene is local­
ized to chromosomal locus llq l3 -q te r . GSTP1 is widely ex­
pressed in hum an epithelial tissue, and it  is known to be 
present in the retina, although the cellular location of GSTP1 
w ithin the retina has not been described.
GST proteins have m any other physiological functions be­
sides the ir enzymatic conjugation activities. GSTs m ay act as 
enzymes in other reactions, gene expression regulators, and 
binding proteins. For example, GSTA3-3 is thought to be the 
main enzyme involved in a glutathione-dependent double-bond 
shift reaction in steroid biosynthesis (34), and GSTP1 can act 
as a retinoic acid cis-trans isom erase in a glutathione-indepen­
dent m anner (35). O ther GSTs are involved in gene regulation 
and therefore used as therapeutic targets in diseases such as 
bronchial asthm a and cancer (36). Reactive oxygen species
Fig. 8. C onfocal im m unolocalization  of GSTP1 and  cone a r re s ­
tin  in  hum an  m acula n e a r  th e  fovea. Immunoreactivity with a 
polyclonal antibody directed against GSTPt (red) was observed predom­
inantly over the  outer and inner plexiform layers and was completely 
excluded from nuclei. Cone photoreceptors were revealed by coincuba­
tion with monoclonal antibody 7G6 (32), which recognizes cone arrestin  
(green). ONL, outer nuclear layer; OPL, outer plexiform layer (also 
known as the receptor axon or Henle fiber layer); INL, inner nuclear 
layer; IPL inner plexiform layer; GCL, ganglion cell layer; NFL, nerve 
fiber layer. Magnification bar = 20 /.irn. Aliquots of recombinant hum an 
GSTPt and partially  purified hum an m acular XBP (before the  final gel 
filtration step) were subjected to SDS-PAGE and blotted, and the mem­
brane was incubated with the  same polyclonal antibody used for immu­
nocytochemistry. Membranes were developed with an enhanced chemi­
luminescence W estern blot k it to visualize immunoreactive bands. Lane
I, hum an recombinant GSTPt; lane 2, partially  purified hum an macu­
lar XBP. The fa in t band a t 28 kDa in both lanes is presumed to be a 
splice varian t or a posttranslational modification.
activate gene transcription through the regulatory element of 
GSTs known as an antioxidant-responsive element. Activation 
of genes containing an antioxidant-responsive elem ent could 
lead to the induction of enzymes th a t protect the cells from 
endogenous and/or exogenous compounds th a t undergo redox 
cycling and form reactive oxygen species (36). Much in terest is 
currently being focused on the Pi class of GST because the gene 
is up-regulated during the early stages of oncogenesis, and i t  is 
the most significantly overexpressed GST gene in m any hum an 
tum ors, including gliomas (37).
I t has long been known th a t some GSTs function as binding 
proteins for small hydrophobic molecules. In fact, as far back as 
the 1970s, some forms of GST were nam ed “ligandins” due to 
the ir abilities to bind bilirubin and other toxic m etabolites with 
high affinity (38). More recently, a GST isoform in maize was 
reported to bind and protect protoporphyrin from oxidation 
(39). In plants, some GSTs are reported to be auxin-binding 
proteins (40).
Before th is report, GSTs were not known to have any direct 
physiological interactions with carotenoids. Using recombinant 
hum an GSTP1, we were able to dem onstrate th a t both zeaxan­
thin diastereom ers normally present in the hum an macula 
bind saturably and with submicromolar affinity. Absorption 
and CD spectral studies w ith d ietary (3i?,3'i?)-zeaxanthin and 
nondietary (3i?,3'S-/neso)-zeaxanthin provide further support 
for a  strong and specific interaction with GSTP1. Comparable 
studies w ith other commercially available isoforms of hum an 
GST (GSTA1 and GSTM1) and other m am m alian xanthophyll 
carrier proteins (tubulin, albumin, HDL, LDL, and j3-lactoglob- 
ulin) showed little or no evidence of specific interactions with 
zeaxanthin.
Several common polymorphisms of GSTP1 are known to 
alter the small molecule binding properties and glutathione 























in E scherichia coli (41). Some of these activity-altering poly­
morphisms have been associated w ith increased risk of cortical 
cataracts in the hum an lens, a tissue known to contain GSTP1 
and both forms of zeaxanthin (2, 42). W hereas the association 
of risk of age-related m acular degeneration with polymor­
phism s of glutathione S -transferase Mu and Theta isoforms 
has been examined (43), no comparable studies of GSTP1 poly­
morphisms have been reported. I f  ra re  or common polymor­
phism s or m utations in GSTP1 decrease the ability of GSTP1 to 
bind zeaxanthin and other carotenoids, then elevated risk  of 
age-related m acular degeneration m ight be expected due to 
abnormally low levels of m acular carotenoid pigment.
It is clear from the studies reported here th a t GSTP1 is a 
zeaxanthin-binding protein, bu t the hum an recom binant pro­
tein differs from hum an m acular XBP in several ways. First, 
XBP purified from hum an m acula copurifies with both lutein 
and zeaxanthin, w hereas GSTP1 binds only d ietary zeaxanthin 
and nieso-zeaxanthin. Second, hum an m acular XBP is mem­
brane-associated and requires CHAPS detergent solubilization 
for stability, whereas hum an recom binant GSTP1 is a soluble 
protein. In only a few cases have GSTs been reported to be 
membrane-associated (36). At present, these discrepancies re­
main unexplained, but it is possible th a t hum an m acular XBP 
is a form of GSTP1 th a t is posttranslationally modified in such 
a way as to m ake it more lipophilic. Posttranslational modifi­
cations could also alter its  ligand binding affinity and specific­
ity. Alternatively, one of the as yet unidentified proteins th a t 
copurifies w ith GSTP1 in our m acular XBP preparations may 
be a lutein-binding protein.
The function of GSTP1 in the m acula rem ains to be explored. 
If  i t  is acting solely as a zeaxanthin uptake and stabilization 
protein, then its retinal distribution would be expected to m ir­
ror the distribution of zeaxanthin in the retina, w ith high 
concentrations in the inner and outer plexiform layers of the 
m acula near the fovea, and much lower levels elsewhere in the 
retina. O ur initial immunocytochemistry studies of GSTP1 lo­
calization in hum an m acula support this concept (Fig. 8 ). I t is 
also possible th a t GSTP1 m ay possess an enzymatic activity 
toward xanthophyll carotenoids. For example, the glutathione- 
catalyzed double-bond shift reaction m ediated by GSTA3-3 is 
very analogous to the double-bond shift reaction required for 
the postulated enzymatic conversion of (3i?,3'i?,6'i?)-lutein to 
(3i?,3 'S-7?ieso)-zeaxanthin (44, 45). Finally, it is possible th a t 
interactions with the GSTP1 protein m ay enhance the antiox­
idan t function of zeaxanthin w ithin the m acula and retina. Our 
discovery th a t GSTP1 is a zeaxanthin-binding protein has im­
plications beyond the eye, as well, because GST proteins and 
carotenoids appear to play im portant roles in protection against 
cancer and systemic disorders associated with oxidative stress. 
Additional studies of the physiological interactions of GST pro­
teins and xanthophyll carotenoids in the eye and elsewhere in the 
body should prove to be fruitful areas of investigation.
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